SOURCE: StockCall


September 01, 2010 09:19 ET

Equity Research on GlaxoSmithKline and Abbott Laboratories - The Emerging Markets Opportunities

JOHANNESBURG, SOUTH AFRICA--(Marketwire - September 1, 2010) - offers investors comprehensive research on the major drug manufacturers industry and has completed analytical research on GlaxoSmithKline (NYSE: GSK) and Abbott Laboratories (NYSE: ABT). Register with us today at to have free access to these researches. 

With many patents for successful brand name drugs already expired or set to expire over the next year, generic companies are eating into major drug producer's profits. Companies in the Drug Manufacturing-Major industry are looking to research and development, joint ventures and emerging markets to keep profits up. Register now at to have free access to our reports on the major drug manufacturers industry. is an online platform where investors doing their due-diligence on the major drug manufacturers industry can have easy and free access to our analyst research and opinions on GlaxoSmithKline plc and Abbott Laboratories; investors and shareholders of these companies can simply register for a complimentary membership at

While there have been many lucrative and curative developments in the industry over the last few years, companies are struggling to find the next big wonder cure. Companies are hoping that their research and development into the treatment of cancer, HIV, epilepsy and obesity will prove bountiful in the future. Visit to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

Declines in US profits due to generic alternatives and a weak economy have sent companies into emerging markets. Companies like GlaxoSmithKline plc and Abbott Laboratories are now expanding in South America, and Asia, particularly India, with positive results. As the global economy threatens to descend again, drug manufacturers are looking to diversify their revenue streams in an attempt to stay afloat. GlaxoSmithKline plc and Abbott Laboratories research reports are accessible for free by registering today at or

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information